CoreAge Rx vs FormBlends
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and FormBlends head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 57 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make FormBlends a bad call — it's best for people comparing compounded prepaid plans who check the actual first payment, renewal schedule, pharmacy assignment and laboratory costs. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | FormBlends |
|---|---|---|
| Brief Score | 94/100 (A) | 57/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | First month $99; standard monthly $190 Subscribe & Save monthly renewal $165; upfront plans $399/three months, $714/six months, $1,188/year. Renewal credit $25 per plan; confirm actual intro invoice and selected supply. Review/supplies/shipping included, labs extra. Provider nonprescription: full refund. Dispensed/shipped drugs nonreturnable; damage/incorrect reports within seven days. Cancel subscription by email before next billing; individual state eligibility checked. Full price detailsCompounded semaglutide weekly program offered; complete selected-prescription quote unknown; first month $99 then $190 monthly or $165 Subscribe and Save renewal; upfront plans $399/three months, $714/six months, $1,188/year; labs extra |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | First month $149; standard monthly $239 Subscribe & Save monthly renewal $214; upfront plans $627/three months, $1,194/six months, $2,148/year. Renewal credit $25 per plan; confirm actual intro invoice and selected supply. Review/supplies/shipping included, labs extra. Provider nonprescription: full refund. Dispensed/shipped drugs nonreturnable; damage/incorrect reports within seven days. Cancel subscription by email before next billing; individual state eligibility checked. Full price detailsCompounded tirzepatide weekly program offered; complete selected-prescription quote unknown; first month $149 then $239 monthly or $214 Subscribe and Save renewal; upfront plans $627/three months, $1,194/six months, $2,148/year; labs extra |
| Coverage | US only; restrictions by state, confirmed at intake | Availability checked for patient address and clinician/pharmacy licenses; the reported 36-state/territory shipment sample is historical, not a guaranteed service map |
| Brand-name access | Not confirmed | The reviewed GLP-1 programs are compounded; discussion of branded products does not establish a current branded prescribing offer. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
FormBlends: Sema $99 first/$190 standard; tirzepatide $149/$239. Long plans prepaid; Subscribe & Save renewal subtracts $25 per plan. Review/supplies/shipping included, labs extra; state access individual, not inferred from shipment count.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.